Broad Institute
MAY 14, 2024
“Bill Studier’s development of T7 phage RNA polymerase for use in preparing RNA templates for multiple uses in research labs worldwide has been a truly revolutionary technical advance for the entire field of molecular biology,” said Joan Steitz, the Sterling Professor of Molecular Biophysics and Biochemistry at Yale University.
Drug Target Review
NOVEMBER 27, 2023
a biopharmaceutical company, since February 2015. Dr Worland was an NIH postdoctoral fellow in molecular biology at Harvard University and completed a Ph.D. Prior to Anadys Pharmaceuticals, Inc., Dr Worland was Vice President and Head of Antiviral Research at Pfizer Inc. and Vice President at WarnerLambert Co.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
NOVEMBER 23, 2020
Zhang, who founded Legend Biotech in 2015 as a subsidiary of parent company GenScript, a company he also co-founded, had been under residential surveillance in connection with an investigation by the Customs Anti-Smuggling Department of Zhenjiang in China since Sept. as a director of molecular biology.
Drug Target Review
OCTOBER 3, 2024
2015 May;521(7552):274–6. Methods in Molecular Biology. Journal of Molecular Biology. FDA no longer needs to require animal tests before human drug trials [Internet]. www.science.org. Available from: [link] Baker M. Reproducibility crisis: Blame it on the antibodies. Bradbury ARM, Trinklein ND, Thie H, et al.
Drug Target Review
AUGUST 29, 2024
He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.
DrugBaron
NOVEMBER 22, 2022
In 2015, Methuselah Health was founded to investigate the role of proteome instability during ageing, and the extent to which the instability of specific proteins might underlie development of age-related diseases – a concept that arose from the ground-breaking work of Professor Miro Radman (which DrugBaron highlighted previously).
The Pharma Data
SEPTEMBER 15, 2020
“When Amgen first partnered with us in 2015, MBC BioLabs was a single site in San Francisco hosting 40 companies. Each site has a complete molecular biology core facility that allows companies to do experiments on day one, not year one.
Expert insights. Personalized for you.
84 
Let's personalize your content